Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

AVEO Pharmaceuticals Inc. AVEO

Healthcare Biotechnology
AVEO Pharmaceuticals Inc is a commercial-stage, oncology-focused biopharmaceutical company engaged in offering medicines that provide a better life for patients with cancer. The company markets FOTIVDA (tivozanib) in the United States.


NDAQ:AVEO - Post by User

AVEO Pharmaceuticals Inc. > Wow
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by ARNULFon Jul 04, 2018 9:50am
21 Views
Post# 28266492

RE:RE:RE:Wow

RE:RE:RE:WowWell I guess something to a buyout with AVEO. Thanks to the other board I’m monitoring https://www.businesswire.com/news/home/20180201006348/en/AVEO-Announces-Appointment-John-H.-Johnson-Board
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities